Ultima Genomics IPO
Ultima Genomics is a genomics company that develops ultra-high throughput DNA sequencing technology. The company aims to dramatically reduce the cost of genome sequencing through its innovative sequencing platform and chemistry. Investors are interested in Ultima Genomics' IPO potential due to the growing genomics market and the company's potential to disrupt DNA sequencing costs.
Key Facts
| Industry | Genomic Sequencing Technology |
| Founded | 2016 |
| Headquarters | Newark, CA |
| Employees | ~400 |
| Website | ultimagenomics.com |
| Funding | Series B in 2022 raised $600M at $5.8B valuation |
About Ultima Genomics
Ultima Genomics is developing next-generation DNA sequencing technology aimed at dramatically reducing the cost of genomic sequencing to enable population-scale genomics studies. The company's proprietary sequencing platform uses a novel approach that combines unique chemistry and engineering to achieve high-throughput, low-cost sequencing without sacrificing accuracy. Ultima's goal is to make whole genome sequencing accessible at a price point that could enable routine clinical use and large-scale research applications. The company emerged from stealth mode in 2022 and represents a significant challenge to incumbent players in the genomics market, particularly Illumina's dominance in high-throughput sequencing.
IPO Status
Ultima Genomics has not announced plans for an initial public offering and remains privately held. The genomics company has raised significant venture capital funding to develop and commercialize its DNA sequencing technology, but has not disclosed IPO timeline or preparation activities. As a company developing potentially disruptive genomics technology, Ultima Genomics could be attractive to public market investors given the growth in the genomics and precision medicine markets. However, there are no confirmed details about the company's IPO plans, valuation expectations, or any engagement with investment banks for a potential offering. The company appears focused on advancing its technology and building commercial traction in the private market.
Competitors
Frequently Asked Questions
Does Ultima Genomics have a stock?
No, Ultima Genomics has not had an IPO and remains a private company. The genomics technology company has not announced any plans to go public.
When is the Ultima Genomics IPO date?
Ultima Genomics has not announced an IPO date or timeline for going public. There are no confirmed details about when or if the company plans to pursue an initial public offering.
How can I buy Ultima Genomics stock?
You cannot buy Ultima Genomics stock as the company is privately held and not available on public stock exchanges. If the company decides to go public in the future, shares would become available through brokers.
Stay Updated on the Ultima Genomics IPO
Get real-time alerts when Ultima Genomics files for an IPO, prices shares, or begins trading.
Get IPO Alerts